Lucky to be able to work with and learn from such dedicated and caring diabetes clinicians like Devin! Boston Medical Center

Cant wait for the scientific sessions, great learning &networking! Register today, hope to see you there.

I’ll be speaking on a panel Saturday: “The Role of the Interdisciplinary Team in Technology Onboarding in Primary Care” #diabetescare #diabetestechnology #diabeteseducation

I’m so excited to join Susan G. Weiner, RD as she hosts the next episode of American Diabetes Association - DiabetesPro “Ask the Expert” event on medications. Join on 4/9 ! #diabetes #pharmacist #TwitteRx

Encourage people living with diabetes to join us for an Ask the Experts event on Tuesday, April 9 at 2:00 p.m. ET. We'll be discussing medications used to manage diabetes and the types that can work best. Register at bit.ly/49bxEcK. #KnowDiabetesbyHeart
Susan G. Weiner, RD

Great news! Hope to see improvements in production with expanded access and coverage. #MedTwitter

Do you use Humalog or Lilly’s lispro in 10mL bottles? It may be hard to come by starting April, per Lilly.

lilly.com/our-medicines/…

“Medicare couldn’t cover #Wegovy for #weightloss . But now that it’s also a heart drug, the door is open”

STAT Rachel Cohrs Zhang

statnews.com/2024/03/14/med…

#cardiotwitter #obesity

Phase 2 does not mean inferior program or candidate.

Decrease candidate pool + ⬆️ competition for certain programs = ⬆️ unmatched programs/candidates

Just my opinion

#TwitteRx We have 1 PGY1 position at Duke Raleigh Hospital available in Phase II of the match. Please share with candidates who are looking for a great well rounded PGY1!

Looking forward to the conference MA Coordinating Body ADCES register today: adces.org/events/unliste…

Thanks to CeQur for sponsoring Fridays dinner program!

#diabetes #diabetes education #cardiorenalmetabolic #diabetes complications #diabetes conference

Today, we approved a new indication for use for an injectable medication to reduce the risk of cardiovascular death, heart attack and stroke in adults with cardiovascular disease and either obesity or overweight. fda.gov/news-events/pr…

This injection should be used in…

I appreciate Eli Lilly and Company highlighting the appropriate vs. inappropriate uses of anti #obesity #medicine

cnn.com/2024/03/07/hea…

It was a real pleasure working with Wendy St. Peter and Jay SHUBROOK on this review discussing opportunities for pharmacists to improve outcomes for people with T2D and CKD JCM MDPI

doi.org/10.3390/jcm130…

Today, FDA cleared for marketing the first over-the-counter (OTC) continuous glucose monitor (CGM). fda.gov/news-events/pr…

Announcement from Novo Nordisk re the FLOW trial:

Semaglutide reduced the risk of 50% decline in eGFR, kidney failure, or death due to kidney or cardiovascular disease by 24%

Results to be presented this year by trial PI Vlado Perkovic & colleagues

novonordisk.com/content/nncorp…

If you work in healthcare, highly recommend this read uché blackstock, md

📢Attention graduating student pharmacy who identify as racially or ethnically minoritized - it's that time of year! Submit your Amazon wishlist today.

Did you know that A1C is not always accurate for people of color living with diabetes? When A1C is often the deciding factor in diagnosis and diabetes management decisions—that’s a big problem. Learn more at bit.ly/3uMayv8.

#TimeInRange #T1D #T2D

💊Only 8% of adults with #obesity in a large health system were prescribed obesity medication from 2015 to 2023, and just 55% of those prescribed medication filled their prescription at least once.

Read more 👇

Hamlet Gasoyan Cleveland Clinic
healio.com/news/endocrino…

Hard to believe 10 years has gone by!